Project description
Whole-blood diagnostics enabling rapid stroke treatment
Stroke is a leading cause of death and disability globally. Rapid intervention – within minutes – is critical to saving lives and to patients’ subsequent quality of life. The level of anticoagulant drugs in a patient’s bloodstream determines which lifesaving treatment can be given, yet currently determining this takes more than 40 minutes. The female-headed Danish SME MEDICQUANT has developed innovative technology to quickly measure drug levels at the point of care, detecting anticoagulants directly from whole blood within 10 minutes. The EU-funded MedicQuant project aims to prepare the technology for commercialisation via activities such as reimbursement analysis, development of regulatory and pricing strategies, and evaluation of willingness to buy.
Objective
MedicQuant is an in vitro diagnostic company where we have invented a deep-tech platform technology that will revolutionize small molecule diagnostics. Our first product, DoaQuant, focuses on improving stroke management. In the event of stroke rapid treatment is vital for survival and every minute matters. It is crucial to determine the level of anticoagulant (AC) drugs in these patients, as this determines which lifesaving treatment can be given. Current diagnostic solutions take more than 40 minutes thus risking patients’ lives. DoaQuant can rapidly provide clinicians with the answer they need to determine the correct life-saving management in stroke, thus greatly reducing delay in treatment, mortality, and disability. Dr. Line Debois is CEO and co-founder of MedicQuant and has, through her academic career, researched biosensors concluding in the co-invention of the technology behind MedicQuant. She has taken the position of CEO in MedicQuant since incorporation, with the vision to lead the company to success and make a difference in the healthcare system. The overall goal with the activities performed during the Women TechEU program is commercial maturation of MedicQuant and preparing for VC fundraising. This will be achieved through specific tasks and by further developing CEO Line’s commercial and leadership skills. The specific activities to achieve this is making a market access strategy (through reimbursement analysis, regulatory strategy, pricing strategy and willingness to buy), preparation of documentation portfolio for investment and further developing commercial skills through the mentoring program that are needed for VC fundraise and manage a company in growth. This program will directly help overcoming the most crucial commercial challenges that both MedicQuant and Line as CEO are currently facing, thereby enabling MedicQuant to become a female lead success, empowering women in deep-tech and fostering further diversity in the life-science sector.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- engineering and technology materials engineering amorphous solids amorphous semiconductors
- engineering and technology electrical engineering, electronic engineering, information engineering electronic engineering sensors biosensors
- social sciences sociology demography mortality
- medical and health sciences basic medicine neurology stroke
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.3.2 - European innovation ecosystems
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-CSA - HORIZON Coordination and Support Actions
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-EIE-2022-SCALEUP-02
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
8200 AARHUS N
Denmark
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.